Are you a student? http://kkc.kg/archives/1318 buy neoral On Wednesday, Pfizer said tofacitinib met its primaryeffectiveness goal in a separate Phase III psoriasis study,called OPT Retreatment, which lasted 56 weeks and compared the 5milligram and 10 milligram doses of tofacitinib to a placebo.